BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Ischemia
,
Lymphocyte
,
Human chorionic gonadotropin
,
Fenofibrate
,
rs2230926
,
GATA1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
MEK kinase
Summary
General Info
Curated Studies
Most Correlated Studies
Monocytes from blood treated with TPL2 or MEK inhibitors in the presence or absence of LPS
Metastatic melanoma cells BRAF-V600E with MEK inhibitor resistance and NICD overexpression
Colorectal cancer HCT-15 cells treated with MEK/TNKS inhibitors GDC-0973 or G007-LK respectively
Gastric cancer cells treated with MEK inhibitor PD0325901
Bone marrow tissue of mice transplanted with murine AML cells MEK inhibitor resistant
Explore Curated Studies Results
Literature
Most Relevant Literature
The Role of MAP3K1 in the Development of the Female Reproductive Tract.
Insights into the regulation of MAP3K1 in hair follicle stem cells by transcriptome analysis.
Differential expression of MEKK subfamily genes in Capsicum annuum L. in response to abscisic acid a…
A role for peroxiredoxins in H2O2- and MEKK-dependent activation of the p38 signaling pathway.
Pathogenic Variants in MAP3K1 Cause 46,XY Gonadal Dysgenesis: A Review.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors
Phase Ib Study of PI3(Phosphoinositol 3)-Kinase Inhibitor Copanlisib With MEK (Mitogen-activated Pro…
Randomized Phase II Study of AZD6244 (Mitogen-activated Protein Kinase Inhibitor) MEK-Inhibitor With…
A Multicentre, Open Label, Phase 1 Trial in Japan of the Mitogen Activated Protein Extracellular Sig…
Study of Ulixertinib for Patients With Advanced Malignancies Harboring MEK or Atypical BRAF Alterati…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ